NRIX
Price
$9.11
Change
-$0.23 (-2.46%)
Updated
Sep 2 closing price
Capitalization
696.45M
36 days until earnings call
PROK
Price
$2.30
Change
-$0.06 (-2.54%)
Updated
Sep 2 closing price
Capitalization
310.49M
76 days until earnings call
Interact to see
Advertisement

NRIX vs PROK

Header iconNRIX vs PROK Comparison
Open Charts NRIX vs PROKBanner chart's image
Nurix Therapeutics
Price$9.11
Change-$0.23 (-2.46%)
Volume$1.23M
Capitalization696.45M
ProKidney
Price$2.30
Change-$0.06 (-2.54%)
Volume$1.25M
Capitalization310.49M
NRIX vs PROK Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. PROK commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (NRIX: $9.11 vs. PROK: $2.30)
Brand notoriety: NRIX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 147% vs. PROK: 7%
Market capitalization -- NRIX: $696.45M vs. PROK: $310.49M
NRIX [@Biotechnology] is valued at $696.45M. PROK’s [@Biotechnology] market capitalization is $310.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both NRIX and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 5 bearish.
  • PROK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than PROK.

Price Growth

NRIX (@Biotechnology) experienced а -4.41% price change this week, while PROK (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +24.35%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($696M) has a higher market cap than PROK($310M). PROK YTD gains are higher at: 39.645 vs. NRIX (-50.425). PROK has higher annual earnings (EBITDA): -157.52M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. PROK (295M). PROK has less debt than NRIX: PROK (4.42M) vs NRIX (51.9M). NRIX has higher revenues than PROK: NRIX (88.4M) vs PROK (527K).
NRIXPROKNRIX / PROK
Capitalization696M310M225%
EBITDA-212.78M-157.52M135%
Gain YTD-50.42539.645-127%
P/E RatioN/AN/A-
Revenue88.4M527K16,774%
Total Cash486M295M165%
Total Debt51.9M4.42M1,175%
TECHNICAL ANALYSIS
Technical Analysis
NRIXPROK
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
72%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
66%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
72%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
74%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFCAX38.61-0.12
-0.31%
JHancock Fundamental All Cap Core A
SVXLX68.82-0.60
-0.86%
Smead International Value Inv
FIGFX22.67-0.23
-1.00%
Fidelity International Growth
CLPAX13.90-0.17
-1.21%
Catalyst Nasdaq-100 Hedged Equity A
SPFCX20.17-0.27
-1.32%
PGIM Jennison Focused Growth C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-0.74%
KYMR - NRIX
68%
Closely correlated
-1.32%
IDYA - NRIX
60%
Loosely correlated
-1.52%
DNLI - NRIX
58%
Loosely correlated
-2.43%
CRNX - NRIX
56%
Loosely correlated
+1.11%
BEAM - NRIX
55%
Loosely correlated
-2.91%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-5.60%
CYCC - PROK
57%
Loosely correlated
+5.31%
MBIO - PROK
51%
Loosely correlated
-2.27%
RLYB - PROK
45%
Loosely correlated
-4.21%
RYTM - PROK
40%
Loosely correlated
-1.04%
NRIX - PROK
39%
Loosely correlated
-0.74%
More